### ü´Ä Pulmonary Medicine: Asbestosis ‚Äî Chest CT Findings

#### ‚úÖ True Statements
1. **Asbestosis** is a slowly progressive, diffuse **pulmonary fibrosis** caused by inhalation of **asbestos fibers**.  
2. **Calcified pleural plaques** are evidence of prior **asbestos** exposure and can be detected on chest imaging.  
3. **High-resolution computed tomography (HRCT)** often shows **pleural thickening** and **subpleural linear densities** parallel to the pleura in **asbestosis**.  
4. **Basilar lung parenchymal fibrosis** with **peribronchiolar, intralobular, and interlobular septal fibrosis** is a characteristic HRCT pattern in **asbestosis**.  
5. **Parenchymal bands** and **curvilinear opacities** on chest CT are imaging findings associated with **asbestosis**.  
6. The latency period between initial **asbestos** exposure and symptomatic **asbestosis** is commonly **20 to 30 years**.  
7. Diagnosis of **asbestosis** requires all of the following: evidence of **asbestos exposure** (for example, calcified pleural plaques), an **appropriate latency period**, a **compatible clinical presentation** (progressive dyspnea and reduced lung volumes and/or reduced diffusing capacity), and **consistent imaging results**.  
8. Imaging assessment for suspected **asbestosis** typically includes thin-section chest CT (HRCT) to evaluate pleural and subpleural disease.

#### üí¨ Extra
2. The provided bone-window image demonstrates **calcified pleural plaques** (left panel, yellow arrows) that serve as objective evidence of prior asbestos exposure.  
3. The provided CT (right panel, red arrow) shows **diffuse pleural thickening** consistent with the pleural component of asbestos-related disease.  
5. The provided CT (right panel, black arrow) shows **parenchymal bands** and **curvilinear opacities** at the lung bases consistent with asbestosis-related parenchymal fibrosis.  
7. The listed diagnostic requirements (exposure, latency, compatible symptoms, and consistent imaging) are conjunctive ‚Äî all contribute to establishing the diagnosis rather than any single feature alone.

#### üè∑Ô∏è Tags
#Pulmonology #Asbestosis #PleuralPlaques #ChestCT #OccupationalLungDisease #HRCT

#### üìö Reference
MKSAP (Pulmonary Medicine: Asbestos-Related Lung Disease). *MKSAP 19: Pulmonary Medicine*.

#### üÜî Question ID
PMVDX24017

#### üïí Last Updated
February 2025

---

#### üñºÔ∏è Supplemental Figures
<figure>
  <img src="Diagnose asbestos-related lung disease based on chest CT findings.jpg" alt="Chest CT images showing calcified pleural plaques and parenchymal fibrosis">
  <figcaption><strong>Figure:</strong> Chest CT images demonstrating calcified pleural plaques (left) and basilar parenchymal fibrosis with parenchymal bands and curvilinear opacities (right).</figcaption>
</figure>

---

#### üìñ Related Text
Occupational Lung Disease ‚Äî Key Elements of Occupational Exposure History and Diagnosis

---

### üìò Related Text Derivations

#### ‚úÖ True Statements
1. The **time course** from exposure to the development of signs and symptoms of **occupational lung disease** is highly variable.  
2. **Exposures within the same industry** can vary according to use of best **protective practices** and the **type of workplace**.  
3. **Coal worker's pneumoconiosis** in the United States has substantially decreased since the institution of **federal safety standards**.  
4. **Adequate determination of exposure** requires a clear description of **job duties** and assessment of the **extent of exposure**.  
5. Clinicians should obtain a history of **additional exposures** from **hobbies** and the **home environment**.  
6. Key features of the more frequently encountered **occupational lung diseases** are summarized in a dedicated **table** (Table: Key Features of Occupational Lung Diseases).  
7. Common diagnostic testing for occupational lung diseases is summarized in a dedicated **table** (Table: Common Diagnostic Tests for Occupational Lung Diseases).  
8. When an **occupational lung disease** is suspected, the clinician should request a **Safety Data Sheet** from the patient's employer.  
9. A **Safety Data Sheet** details the **chemical properties** and **known health risks** associated with substances within the workplace.  
10. The **U.S. Occupational Safety and Health Administration (OSHA)** requires that employers make Safety Data Sheets available upon request for employees who work with potentially harmful materials.  
11. For individuals with **undiagnosed disorders**, **persistent unexplained symptoms**, or **permanent impairment** possibly due to an occupational lung disease, **referral to an occupational or environmental lung disease specialist** is appropriate.

#### üí¨ Extra (if applicable)
4. "Adequate determination of exposure" implies obtaining specifics about job tasks and duration to assess exposure extent.  
8. The Safety Data Sheet is obtained from the employer and is intended to inform clinicians and employees about workplace chemicals and risks.  
11. Referral to a specialist is recommended for complex, unexplained, or potentially occupationally related respiratory disorders.

#### üè∑Ô∏è Tags
#OccupationalHealth #WorkplaceSafety #SafetyDataSheet #OSHA #ExposureHistory #Pulmonology

#### üìö Reference
MKSAP (Pulmonary Medicine: Occupational Lung Disease ‚Äî Key Elements of Occupational Exposure History and Diagnosis). *MKSAP 19: Pulmonary Medicine*.

---

#### üìñ Table 1 ‚Äî Patient Questionnaire for Occupational Lung Disease Screening (HTML)

<!--Patient Questionnaire for Occupational Lung Disease Screening-->
<table>
  <caption>Patient Questionnaire for Occupational Lung Disease Screening</caption>
  <thead>
    <tr><th>Occupation</th><th></th></tr>
  </thead>
  <tbody>
    <tr><td>What do you do every day at your job?</td></tr>
    <tr><td>Have you had other duties?</td></tr>
    <tr><td>How long have you been working in this job? Have you had a similar job elsewhere?</td></tr>
    <tr><td>What other types of work have you done? (Obtain a full accounting of other jobs.)</td></tr>
    <tr><td>Have you ever had any of the following occupations: farmworker, painter, sandblaster, pipefitter, automotive mechanic, welder, insulator, vineyard worker, carpenter, laboratory worker, dockworker, smelter operator?</td></tr>
    <tr><td>Have you ever worked in any of the following locations: mine, quarry, pulp mill, bakery, foundry, railroad, paper mill, plastic factory, tunnel construction?</td></tr>
  </tbody>
  <thead>
    <tr><th>Type and Extent of Exposure</th><th></th></tr>
  </thead>
  <tbody>
    <tr><td>Describe your work area. Is there adequate ventilation? Is there visible dust in the air? Is visibility across the work area limited because of the amount of dust in the air?</td></tr>
    <tr><td>Are you exposed to vapors, gases, dust, or fumes in your work?</td></tr>
    <tr><td>Does your employer require you to wear personal protective equipment? If so, do you wear it for the full extent of your exposure?</td></tr>
    <tr><td>Do you know the amount and type of chemicals used?</td></tr>
    <tr><td>Do you have Safety Data Sheets from your workplace?</td></tr>
  </tbody>
  <thead>
    <tr><th>Temporal Relationship of Symptoms to the Work Environment</th><th></th></tr>
  </thead>
  <tbody>
    <tr><td>Do you receive an annual physical examination and spirometry testing? If so, what have been the results?</td></tr>
    <tr><td>Before symptoms began, were there any changes in the processes at work or new exposures?</td></tr>
    <tr><td>When you are off work, do your symptoms improve?</td></tr>
    <tr><td>Are there others at work who have developed similar symptoms?</td></tr>
    <tr><td>Has a process change at work resulted in improved symptoms?</td></tr>
  </tbody>
  <thead>
    <tr><th>Other Relevant Exposures</th><th></th></tr>
  </thead>
  <tbody>
    <tr><td>How do you spend your time?</td></tr>
    <tr><td>Have you ever smoked, inhaled, or injected chemicals for nonmedical purposes?</td></tr>
    <tr><td>Do you perform other activities that may expose you to organic or inorganic dust (e.g., refurbishing old cars or woodworking)?</td></tr>
    <tr><td>Does your current environment have a humidifier, sauna, hot tub, water damage, mold, birds, or other animals?</td></tr>
    <tr><td>Have you always lived in the area?</td></tr>
    <tr><td>Have you traveled recently?</td></tr>
  </tbody>
  <tfoot>
    <tr><td colspan="2"><small>a Obtain a full accounting of other jobs.</small></td></tr>
  </tfoot>
</table>

---

#### üìñ Table 2 ‚Äî Indications for Diagnostic Tests for Occupational Lung Diseases (HTML)

<!--Indications for Diagnostic Tests for Occupational Lung Diseases-->
<table>
  <caption>Indications for Diagnostic Tests for Occupational Lung Diseases</caption>
  <thead>
    <tr><th>Test</th><th>Occupational Lung Disease Indication</th></tr>
  </thead>
  <tbody>
    <tr><td>High-resolution chest CT</td><td>Diffuse parenchymal lung disease (DPLD), dust-related pneumoconiosis, hypersensitivity pneumonitis</td></tr>
    <tr><td>Pulmonary function testing</td><td>Occupational asthma, occupational chronic obstructive pulmonary disease (COPD), DPLD</td></tr>
    <tr><td>Methacholine challenge test (if occupational asthma is suspected)</td><td>Occupational asthma</td></tr>
    <tr><td>Bronchoscopy with bronchoalveolar lavage</td><td>Hypersensitivity pneumonitis, chronic beryllium disease</td></tr>
    <tr><td>Bronchoscopic or surgical lung biopsy</td><td>Lung cancer</td></tr>
  </tbody>
  <tfoot>
    <tr><td colspan="2"><small>Note: DPLD = diffuse parenchymal lung disease.</small></td></tr>
  </tfoot>
</table>

#### ‚úÖ True Statements (from Table 2)
23. **High-resolution chest CT** (HRCT) is indicated for **diffuse parenchymal lung disease**, dust-related pneumoconiosis, and hypersensitivity pneumonitis.
24. **Pulmonary function testing** is indicated for **occupational asthma**, occupational chronic obstructive pulmonary disease (occupational COPD), and diffuse parenchymal lung disease (DPLD).
25. **Methacholine challenge test** (if occupational asthma is suspected) is indicated for **occupational asthma**.
26. **Bronchoscopy with bronchoalveolar lavage** is indicated for **hypersensitivity pneumonitis** and **chronic beryllium disease**.
27. **Bronchoscopic or surgical lung biopsy** is indicated for evaluation of **lung cancer**.
28. The table footnote defines **DPLD** as **diffuse parenchymal lung disease**.

---

#### üìñ Table 3 ‚Äî Characteristics of Various Occupational Lung Diseases (HTML)
(Note: this table was supplied as two images and has been combined below.)

<!--Characteristics of Various Occupational Lung Diseases-->
<table>
  <caption>Characteristics of Various Occupational Lung Diseases</caption>
  <thead>
    <tr><th>Occupational Pulmonary Disease</th><th>Comments</th></tr>
  </thead>
  <tbody>
    <tr><td>Occupational asthma</td><td>Key is to diagnose airways disease in conjunction with exposure at work. Pre- and post-shift spirometry, serial peak flow measurements, methacholine challenge test, specific inhalation challenge test; serologic tests for specific antigens.</td></tr>
    <tr><td>Occupational COPD</td><td>Pulmonary function tests show obstruction; may also develop in patients who do not smoke from occupational exposures.</td></tr>
    <tr><td>Diffuse parenchymal lung diseases</td><td>Pulmonary function tests show restrictive or mixed physiology. High-resolution CT is imaging modality of choice.</td></tr>
    <tr><td>Silica (acute silicosis, chronic simple silicosis, chronic complicated silicosis, accelerated silicosis)</td><td>Silica exposure in industries that cut or grind silica-containing materials, use sandblasting, or perform hydraulic fracking for natural gas; associated with increased risk for tuberculosis and autoimmune diseases. Ground-glass, nodular, interstitial, or fibrotic infiltrates on imaging.</td></tr>
    <tr><td>Coal (simple or complicated coal worker pneumoconiosis)</td><td>Improved mine safety standards have decreased incidence. Nodular or fibrotic changes on imaging.</td></tr>
    <tr><td>Nonsynthetic fibers (cotton, jute, flax, and hemp ‚Äî byssinosis; cotton worker lung; mill fever)</td><td>Dust exposure during the early manufacturing process; re-exposure elicits symptoms within hours ("Monday fever"). Especially common in regions where cotton industries flourish.</td></tr>
    <tr><td>Stone (fine particles of stone; stonecutter lung, chalicosis)</td><td>Symptoms develop slowly over years; treatment focuses on symptom management.</td></tr>
    <tr><td>Asbestos-related pleuropulmonary disease</td><td>Exposure often related to insulation installation, shipbuilding, and demolition work. Long latency (>25 years) from exposure to onset; amphibole asbestos more pathogenic than serpentine asbestos. Pulmonary fibrosis and pleural disease (effusions, pleural plaques, pleural thickening).</td></tr>
    <tr><td>Metal-induced lung disease</td><td>Cobalt: giant cell interstitial pneumonitis. Indium: pulmonary alveolar proteinosis. Ground-glass opacities on imaging.</td></tr>
    <tr><td>Occupational hypersensitivity pneumonitis (extrinsic allergic alveolitis)</td><td>Fibrotic or nonfibrotic.</td></tr>
    <tr><td>Chronic beryllium disease (CBD)</td><td>Beryllium use in aerospace, automotive, nuclear, and telecommunication industries; exposure in a patient with a granulomatous lung disease should prompt consideration of CBD. Diagnosed by beryllium lymphocyte proliferation test on bronchoalveolar lavage.</td></tr>
    <tr><td>Lung malignancies</td><td>Lung cancer (histologic subtypes vary with type of exposure) and mesothelioma (strongly associated with asbestos exposure).</td></tr>
  </tbody>
</table>

#### ‚úÖ True Statements (from Table 3)
29. The key to diagnosing **occupational asthma** is to diagnose **airways disease** in conjunction with **exposure at work**.
30. Diagnostic modalities for **occupational asthma** listed include pre- and post-shift spirometry, serial peak flow measurements, methacholine challenge test, specific inhalation challenge test, and serologic tests for specific antigens.
31. **Pulmonary function tests** show **obstruction** in **occupational COPD**.
32. Occupational exposures may cause **occupational COPD** in patients who do not smoke.
33. **Pulmonary function tests** show **restrictive or mixed physiology** in **diffuse parenchymal lung diseases**.
34. **High-resolution CT** is the imaging modality of choice for **diffuse parenchymal lung diseases**.
35. **Silica** exposure occurs in industries that cut or grind silica-containing materials, use sandblasting, or perform hydraulic fracking for natural gas.
36. **Silica exposure** is associated with an increased risk for **tuberculosis** and **autoimmune diseases**.
37. Imaging findings for **silica-related disease** include ground-glass, nodular, interstitial, or fibrotic infiltrates.
38. Improved mine safety standards have decreased the incidence of **coal worker pneumoconiosis**.
39. Imaging findings for **coal worker pneumoconiosis** include nodular or fibrotic changes.
40. **Nonsynthetic fiber** exposure (cotton, jute, flax, hemp) causes symptoms with re-exposure that elicit symptoms within hours ("Monday fever").
41. Nonsynthetic fiber‚Äìrelated disease is especially common in regions where cotton industries flourish.
42. For **stone** (stonecutter lung, chalicosis), symptoms develop slowly over years and treatment focuses on symptom management.
43. **Asbestos-related pleuropulmonary disease** exposure is often related to insulation installation, shipbuilding, and demolition work.
44. **Asbestos-related pleuropulmonary disease** has a long latency greater than 25 years from exposure to onset.
45. **Amphibole asbestos** is stated to be more pathogenic than **serpentine asbestos**.
46. **Asbestos-related pleuropulmonary disease** includes pulmonary fibrosis and pleural disease (effusions, pleural plaques, pleural thickening).
47. **Metal-induced lung disease** examples: cobalt is associated with giant cell interstitial pneumonitis and indium is associated with pulmonary alveolar proteinosis.
48. **Metal-induced lung disease** may show ground-glass opacities on imaging.
49. **Occupational hypersensitivity pneumonitis** can be fibrotic or nonfibrotic.
50. **Chronic beryllium disease** (CBD) is associated with beryllium use in aerospace, automotive, nuclear, and telecommunication industries.
51. **Chronic beryllium disease** should be considered in a patient with a granulomatous lung disease and relevant exposure.
52. **Chronic beryllium disease** is diagnosed by the beryllium lymphocyte proliferation test on bronchoalveolar lavage.
53. **Lung malignancies** associated with occupational exposure include lung cancer (with histologic subtypes that vary with type of exposure) and mesothelioma, which is strongly associated with asbestos exposure.